These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14872499)

  • 21. Linkage disequilibrium between TNF-α-308 G/A promoter and histocompatibility leukocyte antigen alleles in Han-nationality lung transplant recipients from Eastern China.
    Huijun M; Ji Z; Ping X; Jingyu C; Bin Z
    Exp Clin Transplant; 2013 Jun; 11(3):264-9. PubMed ID: 23176610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA and autoimmunity in scleroderma (systemic sclerosis).
    Arnett FC
    Int Rev Immunol; 1995; 12(2-4):107-28. PubMed ID: 7650416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of two independent risk factors for lupus within the MHC in United Kingdom families.
    Fernando MM; Stevens CR; Sabeti PC; Walsh EC; McWhinnie AJ; Shah A; Green T; Rioux JD; Vyse TJ
    PLoS Genet; 2007 Nov; 3(11):e192. PubMed ID: 17997607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scleroderma: DR antigens, autoantibodies and clinical manifestations.
    Alarcón GS; McCarty GA; Lanyon P; Phillips RM; Acton RT; Barger BO
    Clin Exp Rheumatol; 1987; 5(4):317-21. PubMed ID: 3326691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different distribution of HLA class II and tumor necrosis factor alleles (TNF-308.2, TNFa2 microsatellite) in anti-topoisomerase I responders among scleroderma patients with and without exposure to quartz/metal dust.
    Frank KH; Füssel M; Conrad K; Rihs HP; Koch R; Gebhardt B; Mehlhorn J
    Arthritis Rheum; 1998 Jul; 41(7):1306-11. PubMed ID: 9663489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease.
    Hunt PJ; Marshall SE; Weetman AP; Bunce M; Bell JI; Wass JA; Welsh KI
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):491-9. PubMed ID: 11678832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoglobulin allotype gene polymorphisms in systemic sclerosis: interactive effect of MHC class II and KM genes on anticentromere antibody production.
    Kameda H; Pandey JP; Kaburaki J; Inoko H; Kuwana M
    Ann Rheum Dis; 1998 Jun; 57(6):366-70. PubMed ID: 9771212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-DRB1 and DQB1 genes in anticentromere antibody positive patients with SSc and primary biliary cirrhosis.
    Akimoto S; Abe M; Ishikawa O; Takagi H; Mori M
    Ann Rheum Dis; 2001 Jun; 60(6):639-40. PubMed ID: 11386258
    [No Abstract]   [Full Text] [Related]  

  • 29. Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency.
    Frezza D; Giambra V; Tolusso B; De Santis M; Bosello S; Vettori S; Triolo G; Valentini G; Ferraccioli G
    Ann Rheum Dis; 2007 Sep; 66(9):1210-5. PubMed ID: 17392350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis.
    Yamamoto-Furusho JK; Uscanga LF; Vargas-Alarcón G; Rodríguez-Pérez JM; Zuñiga J; Granados J
    Immunol Lett; 2004 Aug; 95(1):31-5. PubMed ID: 15325795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA antigens, autoantibodies and clinical subsets in scleroderma.
    Black CM; Welsh KI; Maddison PJ; Jayson MI; Bernstein RM
    Br J Rheumatol; 1984 Nov; 23(4):267-71. PubMed ID: 6593111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Independent contribution of HLA-DRB1 and TNF alpha promoter polymorphisms to the susceptibility to Crohn's disease.
    Kawasaki A; Tsuchiya N; Hagiwara K; Takazoe M; Tokunaga K
    Genes Immun; 2000 Aug; 1(6):351-7. PubMed ID: 11196680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A.
    Pavlova A; Delev D; Lacroix-Desmazes S; Schwaab R; Mende M; Fimmers R; Astermark J; Oldenburg J
    J Thromb Haemost; 2009 Dec; 7(12):2006-2015. PubMed ID: 19817985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-DRw15 is increased in frequency in Japanese scleroderma patients.
    Jazwinska EC; Olive C; Dunckley H; Naito S; Kuseba T; Serjeantson SW
    Dis Markers; 1990; 8(6):323-6. PubMed ID: 2101346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis.
    Dick T; Mierau R; Bartz-Bazzanella P; Alavi M; Stoyanova-Scholz M; Kindler J; Genth E
    Ann Rheum Dis; 2002 Feb; 61(2):121-7. PubMed ID: 11796397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of tumor necrosis factor microsatellite polymorphisms with HLA-DRB1*04-bearing haplotypes in rheumatoid arthritis patients.
    Hajeer AH; Worthington J; Silman AJ; Ollier WE
    Arthritis Rheum; 1996 Jul; 39(7):1109-14. PubMed ID: 8670318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of HLA-DR with progressive systemic sclerosis in Japanese.
    Takeuchi F; Nakano K; Yamada H; Hong GH; Nabeta H; Yoshida A; Matsuta K; Bannai M; Tokunaga K; Ito K
    J Rheumatol; 1994 May; 21(5):857-63. PubMed ID: 8064726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes.
    Acosta-Herrera M; Kerick M; Lopéz-Isac E; Assassi S; Beretta L; Simeón-Aznar CP; Ortego-Centeno N; ; Proudman SM; ; Hunzelmann N; Moroncini G; de Vries-Bouwstra JK; Orozco G; Barton A; Herrick AL; Terao C; Allanore Y; Brown MA; Radstake TR; Fonseca C; Denton CP; Mayes MD; Martin J
    Ann Rheum Dis; 2021 Aug; 80(8):1040-1047. PubMed ID: 34096881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The HLA-DRB, -DQB polymorphism and anti-insulin antibody response in Slovenian patients with type 1 diabetes.
    Battelino T; Ursic-Bratina N; Dolzan V; Stopar-Obreza M; Pozzilli P; Krzisnik C; Vidan-Jeras B
    Eur J Immunogenet; 2003 Jun; 30(3):223-7. PubMed ID: 12787001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of HLA-DRB1*15:02:01, DQB1*05:01:24 and DPB1*13:01:01 in Thai patients with systemic sclerosis.
    Louthrenoo W; Kasitanon N; Wongthanee A; Okudaira Y; Takeuchi M; Nakajima F; Habata M; Masuya A; Noguchi H; Inoko H; Takeuchi F
    HLA; 2022 Dec; 100(6):563-581. PubMed ID: 36054790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.